Gracell Biotechnologies to Participate in Upcoming Virtual Investor Conferences in September

Rhea-AI Summary

Gracell Biotechnologies Inc. (NASDAQ: GRCL) announces participation in virtual conferences including the Citi 16th Annual BioPharma Conference from September 8-10, 2021, featuring a panel on cell therapy on September 9. Additionally, Gracell will participate in the 2021 Wells Fargo Healthcare Conference from September 9-10, with a fireside chat on September 10. These events aim to showcase Gracell's advancements in cell therapies aimed at enhancing cancer treatment. Live webcasts will be available on the Gracell Investor website.

SUZHOU, China and PALO ALTO, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that it will participate in the following upcoming virtual conferences:

Citi 16^th Annual BioPharma Conference

One-on-one and small group meetings: September 8 - 10, 2021

Panel - Exploring the State of Play in Cell Therapy: September 9, 2021, 10:40-11:25 am ET

For more information, please contact your Citi representative.

2021 Wells Fargo Healthcare Conference

One-on-one and small group meetings: September 9 - 10, 2021

Fireside Chat: September 10, 2021, 8:40-9:10 am ET

For more information, please contact your Wells Fargo representative.

The live webcast and replay of the panel and fireside chat can also be accessed through the “Events and Presentations” section of the Gracell Investor website.

About Gracell

Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal production quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit www.gracellbio.com

Follow @GracellBio on LinkedIn

Media contact

Marvin Tang

marvin.tang@gracellbio.com

Investor contact

Gracie Tong

gracie.tong@gracellbio.com

FAQ

What events is Gracell participating in September 2021?

Gracell will participate in the Citi 16th Annual BioPharma Conference and the 2021 Wells Fargo Healthcare Conference.

When is Gracell's panel discussion at the Citi Conference?

The panel discussion titled 'Exploring the State of Play in Cell Therapy' is scheduled for September 9, 2021, from 10:40-11:25 am ET.

What are the dates for the Wells Fargo Healthcare Conference?

The Wells Fargo Healthcare Conference will take place from September 9 to 10, 2021.

What is the significance of Gracell's participation in these conferences?

Gracell's participation highlights its commitment to advancing cell therapies for cancer treatment and engaging with investors and industry experts.

Where can I find the live webcast for Gracell's events?

The live webcast and replay of the events can be accessed through the 'Events and Presentations' section of the Gracell Investor website.